Pharmaceutical

Zydus Lifesciences gets grant for oral suspension of mycophenolate mofetil

Discover the innovative patent by Zydus Lifesciences Ltd for a pharmaceutical oral suspension with mycophenolate mofetil, xanthan gum, and more. Revolutionizing immunosuppressive treatment methods.

Jun 8, 2024 - 04:00
Zydus Lifesciences gets grant for oral suspension of mycophenolate mofetil
Discover the innovative patent by Zydus Lifesciences Ltd for a pharmaceutical oral suspension with mycophenolate mofetil, xanthan gum, and more. Revolutionizing immunosuppressive treatment methods.
Read the original article

Tags:

Previous Article

Avadel Pharmaceuticals gets grant for patent granted for modified release formul...

Next Article

Allscripts Healthcare Solutions gets grant for optimizing patient overview in us...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Sanofi signs agreement to acquire Inhibrx for $1.7bn

Sanofi signs agreement to acquire Inhibrx for $1.7bn

Jan 23, 2024

STAT+: What’s behind the recent surge in Apellis’ stock price? Growing confidence in the safety of its eye treatment

STAT+: What’s behind the recent surge in Apellis’ stock...

Aug 15, 2023

Africa: Unleashing the potential of the new superpower in clinical trials

Africa: Unleashing the potential of the new superpower ...

Mar 21, 2023